Israel Englander’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Israel Englander’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-122,942	Closed	-$24K	–	4867
2019 Q3	$24K	Sell	122,942 -165,346	-57%	-$112K	﹤0.01%	4083
2019 Q2	$251K	Buy	+288,288	New	+$451K	﹤0.01%	3636
2019 Q1	–	Sell	-12,028	Closed	-$28K	–	4504
2018 Q4	$28K	Sell	12,028 -27,978	-70%	-$247K	﹤0.01%	3654
2018 Q3	$593K	Buy	40,006 +19,503	+95%	+$310K	﹤0.01%	3148
2018 Q2	$311K	Buy	+20,503	New	+$348K	﹤0.01%	3376

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Israel Englander's SNNA Position: Q4 2019 in Review

Israel Englander sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 122,942 shares — an estimated $24K sold.

Israel Englander first reported a position in SNNA in Q2 2018 and held it in 5 quarters. The position peaked at $593K in Q3 2018. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

Israel Englander reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Israel Englander sold 122,942 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $24K.
Israel Englander first reported a position in Sienna Biopharmaceuticals, Inc. in Q2 2018 and held it in 5 quarters.
Israel Englander's Sienna Biopharmaceuticals, Inc. position peaked at $593K in Q3 2018.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.